Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Neoplasma|January 1, 1984
Biochemical and histochemical characteristics of target antigen detected by monoclonal antibody HBCA-12 against a membrane component of human mammary carcinoma cell lineJ Kovarík, B Chorváth, J Duraj, et al.
Cancer Detection and Prevention|January 1, 1983
Leukocyte adherence inhibition responses obtained with various tumor extracts in breast cancer patientsJ Kovarík, L Lauerová, J Feit, et al.
Neoplasma|January 1, 1992
Fusion-induced malignancy? A preliminary study. (a challenge to today's common wisdom)M Munzarová, L Lauerová, J Kovarík, et al.
Neoplasma|August 2, 2005
Lack of STAT 1 phosphorylation at TYR 701 by IFNgamma correlates with disease outcome in melanoma patientsV Boudny, L Dusek, L Adámková, et al.
Oncology Reports|April 11, 2001
Relation of prenephrectomy CD profiles and serum cytokines to the disease outcome and response to IFN-alpha/IL-2 therapy in renal cell carcinoma patientsL Lauerová, L Dusek, V Spurny, et al.
Neoplasma|January 1, 1978
Establishment of cell line derived from human malignant melanomaJ Kovarík, J Svejda, J Bucek, et al.
Neoplasma|January 1, 1995
p53 protein overexpression associates with growth patterns rather than with metastasizing in operable breast cancerB Vojtĕsek, J Kovarík, R Nenutil, et al.
Folia Biologica|January 1, 1989
Monoclonal antibodies recognizing different epitopes of cytokeratin No.18B Vojtĕsek, Z Stasková, R Nenutil, et al.
Neoplasma|January 1, 1983
DNCB and PPD skin testing in breast cancerM Munzarová, J Kovarík, E Ninger, et al.
European Journal of Cancer (Oxford, England : 1990)|February 24, 2009
Interferon-alpha treatment may negatively influence disease progression in melanoma patients by hyperactivation of STAT3 proteinL Humpoliková-Adámková, J Kovařík, L Dušek, et al.
Pageof 3